NexTech AR Solutions Reports Preliminary 2nd Quarter 2020 Results
NEW YORK and TORONTO, July 22, 2020 (GLOBE NEWSWIRE) — NexTech AR Solutions (NexTech) (OTCQB: NEXCF) (CSE: NTAR) (FSE: N29), […]
Inuvo Drives Brand Awareness for Dairy Board Using IntentKey Proprietary Artificial Intelligence Technology
LITTLE ROCK, Ark., July 22, 2020 (GLOBE NEWSWIRE) — Inuvo, Inc. (NYSE American: INUV), a leading provider of marketing technology, […]
MCAS Miramar is the first U.S. Military Base to test Verizon 5G Ultra Wideband Service
What you need to know:Verizon and U.S. Marine Corps exploring how 5G can transform communications, energy management, connected vehicles, drones, […]
TSX News -
Revised and Improved Takeover Proposal Received From Shandong Gold
TORONTO, July 22, 2020 (GLOBE NEWSWIRE) — Cardinal Resources Limited (ASX / TSX: CDV) (“Cardinal” or “the Company”) advises that […]
XBiotech Achieves Milestone for Production of its New Potential Blockbuster Anti-IL-1⍺ Therapy
AUSTIN, Texas, July 22, 2020 (GLOBE NEWSWIRE) — XBiotech Inc. (NASDAQ: XBIT) announced today it has achieved a crucial milestone […]
Genius Brands International Provides Business Updates
BEVERLY HILLS, Calif., July 22, 2020 (GLOBE NEWSWIRE) — Following a slate of recent Company news regarding the launch of […]
Nabis Holdings Inc. Provides Update on Arizona Operations and Filing Deadlines
Q1 2020 top line revenue increased 3.3% to CDN$2.3M compared to Q4 F2019Q1 2020 Gross Margin increased 5.5% to 42.3% […]
Kandi Affiliate Fengsheng Announces Subsidy Approval for new Maple 60X
JINHUA, CHINA, July 22, 2020 (GLOBE NEWSWIRE) — Kandi Technologies Group, Inc. (the “Company,” “we” or “Kandi”) (NASDAQ GS: KNDI), […]
Beyond Meat® Announces Partnership With the Social Change Fund to Fight Racial Inequality
EL SEGUNDO, Calif., July 22, 2020 (GLOBE NEWSWIRE) — Beyond Meat, Inc. (NASDAQ: BYND), a leader in plant-based meat, will […]
Genocea Announces Private Placement Financing of Up to $80 Million
CAMBRIDGE, Mass., July 22, 2020 (GLOBE NEWSWIRE) — Genocea Biosciences, Inc. (NASDAQ:GNCA), a biopharmaceutical company developing personalized cancer immunotherapies, today […]
